PTGX Kronos AI forecast
A 30-trading-day price forecast for Protagonist Therapeutics Inc. (PTGX) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Protagonist Therapeutics Inc. at $141.33 on 2026-12-08, +0.1% from the last close of $141.12 on 2026-10-27. Eight out of ten sampled paths end between $128.90 and $149.88, and 5 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PTGX
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $139.42 | $134.17 | $143.20 |
| 2026-11-10 | $139.15 | $134.11 | $149.39 |
| 2026-11-17 | $138.62 | $133.53 | $148.57 |
| 2026-11-24 | $138.46 | $135.38 | $148.68 |
| 2026-12-01 | $139.60 | $130.90 | $145.20 |
| 2026-12-08 | $141.33 | $128.90 | $149.88 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PTGX?
- Kronos AI's median forecast for PTGX is $141.33 in 30 trading days, +0.1% from the last close, with a 10–90% range of $128.90 to $149.88.
- Is the PTGX Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC